Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about INNPF
Recent news which mentions INNPF
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
April 04, 2025
Tickers
AAWH
AYRWF
CGC
GRAM
Tags
WEED
IIPR
Regulations
From
Benzinga
Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth
November 21, 2024
Tickers
INNPF
NEWS
Tags
Earnings
Benzinga
Cannabis
From
Benzinga
CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
May 28, 2024
Tickers
AMZN
CBD
INNO
INNO
Tags
CBD
Benzinga
AMZN
From
Benzinga
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
April 23, 2024
Tickers
INNO
INNO
INNPF
NEWS
Tags
Market News
INNPF
Health Care
From
Benzinga
534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
April 02, 2024
Tickers
CBD
INNO
INNO
INNPF
Tags
CSE:INNO
Iris Bincovich
Cannabis
From
Benzinga
CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
February 13, 2024
Tickers
CBD
INNO
INNO
INNPF
Tags
News
premium
INNO
From
Benzinga
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
December 22, 2023
Tickers
CFO
EEX
INNO
INNO
Tags
CSE:LOWL
TSX:OGI
Ron White
From
Benzinga
More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It
October 23, 2023
Tickers
INNPF
Tags
News
Private Placement
Offerings
From
Benzinga
CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare
September 21, 2023
Tickers
CBD
INNPF
Tags
Financing
Benzinga
CBD
From
Benzinga
Innocan Pharma's Q2 2023 Reports Gross Profit Growth Driven By Robust Subsidiary Sales
August 28, 2023
Tickers
INNPF
Tags
Markets
B/I/ Sky Global Ltd/
Retail Sales
From
Benzinga
Cannabis Stock Gainers And Losers From August 25, 2023
August 25, 2023
Tickers
ACB
ACRHF
AGFY
AKAN
Tags
MAPS
ACB
SHWZ
From
Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
August 21, 2023
Tickers
ACRDF
ACRHF
AKAN
AYRWF
Tags
CXXIF
CANSF
TBPMF
From
Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
August 17, 2023
Tickers
AAWH
ACRDF
ACRHF
AGFY
Tags
CWBHF
CNVCF
ROMJF
From
Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
August 14, 2023
Tickers
ACRHF
AGFY
AKAN
BBRRF
Tags
FFNTF
SOLCF
AKAN
From
Benzinga
Cannabis Stock Gainers And Losers From August 11, 2023
August 11, 2023
Tickers
AAWH
ACRHF
AGFY
ALID
Tags
HEMP
SSIC
CURLF
From
Benzinga
Innocan Pharma Secures $1.4M Via Private Placement
August 04, 2023
Tickers
INNPF
Tags
News
Cannabis
Penny Stocks
From
Benzinga
Innocan Pharma To Secure Up To $3M Via Private Placement Of Units At A 9% Prime Above Share Price
July 25, 2023
Tickers
INNPF
Tags
Market News
INNPF
Penny Stocks
From
Benzinga
Cannabis Stock Movers For July 21, 2023
July 21, 2023
Tickers
ACB
ALID
AYRWF
BBRRF
Tags
DBCCF
BBRRF
CBDD
From
Benzinga
Innocan Pharma Q1 Revenue Grows 500%, Here Is What You Need To Know
June 01, 2023
Tickers
INNPF
Tags
Earnings
Markets
Benzinga
From
Benzinga
Innocan Pharma FY22 Revenue Grows 1205% To $2.6M, Here Is What You Need To Know
April 19, 2023
Tickers
INNPF
Tags
premium
Brandzon Co/
Markets
From
Benzinga
Can Liposomal CBD Injection Help Dogs With Polyarthritis? Innocan Pharma Reports Clinical Success
February 21, 2023
Tickers
INNPF
Tags
Penny Stocks
INNPF
Market News
From
Benzinga
Innocan Pharma Q3 Revenue Grows 700% YoY, Here Is What You Need To Know
November 29, 2022
Tickers
INNPF
Tags
Benzinga
premium
Markets
From
Benzinga
4 CBD Stocks in the Canadian Capital Market
November 02, 2021
Tickers
INNPF
Tags
Opinion
Benzinga
Partner Content
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.